AUXL: Summary for Auxilium Pharmaceuticals, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Tuesday, November 24, 2009, 2:58pm EST - Canadian Markets close in 1 hour and 2 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Auxilium Pharmaceuticals Inc. (AUXL)

At 14:43 EST: 35.49 USD

0.33 (0.94%)

MORE ON AUXL

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Auxilium Pharmaceuticals, Inc. (NasdaqNM:AUXL) Delayed quote data

Last Trade:	35.49 USD
Trade Time:	2:43PM EST
Change:	0.33 (0.94%)
Prev Close:	35.16
Open:	35.35
Bid:	35.48 x 100
Ask:	35.49 x 100
1y Target Est:	34.92

Day's Range:	34.90 - 36.00
52wk Range:	17.96 - 37.28
Volume:	164,146
Avg Vol (3m):	542,682
Market Cap:	1.67B
P/E (ttm):	N/A
EPS (ttm):	-1.27
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add AUXL to Portfolio

Download Data

HEADLINES

•	[video] Collagen Disease Breakthrough
	at TheStreet.com (Mon, Nov 16)

•	AUXILIUM PHARMACEUTICALS INC Financials
	EDGAR Online Financials (Wed, Nov 11)

•	Auxilium Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
	Marketwire (Wed, Nov 11)

•	Auxilium Pharmaceuticals to Present at the Credit Suisse 18th Annual Global Healthcare Conference
	Marketwire (Tue, Nov 10)

•	AUXILIUM PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Thu, Nov 5)

•	AUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
	EDGAR Online (Mon, Nov 2)

•	Auxilium Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference
	Marketwire (Mon, Nov 2)

•	Auxilium Pharmaceuticals, Inc. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
	at Seeking Alpha (Wed, Oct 28)

•	Auxilium Pharmaceuticals, Inc. Earnings Call scheduled for 10:00 am ET today
	CCBN (Wed, Oct 28)

•	UPDATE - Auxilium Pharma posts wider-than-expected Q3 loss
	at Reuters (Wed, Oct 28)

More Headlines for AUXL...

ANALYST

EPS Est (next year) (Dec-09) :	-1.29
EPS Est (in 2 years) (Dec-10) :	-0.46
Avg Rec (current)*:	2.2
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, focuses on developing and marketing products to urologists, endocrinologists, orthopedists, and primary care physicians primarily in the United States.

Full Company Profile

Add to Portfolio

Email to a Friend

•